>
Switch to:

Grifols Asset Impairment Charge

: $0 Mil (TTM As of Jun. 2021)
View and export this data going back to 2011. Start your Free Trial

Grifols's Asset Impairment Charge for the three months ended in Jun. 2021 was $0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2021 was $0 Mil.


Grifols Asset Impairment Charge Historical Data

The historical data trend for Grifols's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Asset Impairment Charge
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.34 78.16 -26.91 -21.69 -20.86

Grifols Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Asset Impairment Charge Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Grifols Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.


Grifols Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Grifols's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


Grifols Business Description

Grifols logo
Industry
Healthcare » Drug Manufacturers NAICS : 325412 SIC : 0
Address
Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 78% of sales in 2019. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics is now roughly 14% of revenue following the Novartis and Hologic deals.

Grifols Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)